These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7197942)

  • 1. [Therapeutic agents for alleviation of muscle weakness in myasthenia gravis (cholinesterase inhibitors)].
    Streller I
    Arzneimittelforschung; 1981; Suppl 27():73-5. PubMed ID: 7197942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of anticholinesterase activity and the effectiveness of anticholinesterase substances].
    Prozorovskĭ VB; Artem'ev VS; Tonkopiĭ VD; Konstorum MG
    Farmakol Toksikol; 1975; 38(4):402-6. PubMed ID: 1213123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and family fact sheet. Myasthenia gravis: maximizing function.
    Kernich CA
    Neurologist; 2008 Jan; 14(1):75-6. PubMed ID: 18195664
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of the end-plate membrane following cholinesterase inhibition, an adjustment to a new working situation.
    Meeter E
    Acta Physiol Pharmacol Neerl; 1969 Jun; 15(2):243-58. PubMed ID: 5799072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pseudoparalytical myasthenia gravis. Current position].
    Yáñez Polo MA
    Rev Clin Esp; 1969 Nov; 115(4):261-70. PubMed ID: 5379539
    [No Abstract]   [Full Text] [Related]  

  • 8. Germine mono- and diacetate in myasthenia gravis.
    Flacke WE; Blume RP; Scott WR; Foldes FF; Osserman KE
    Ann N Y Acad Sci; 1971 Sep; 183():316-33. PubMed ID: 5287830
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylcholinesterase inhibitors in MG: to be or not to be?
    Punga AR; Stålberg E
    Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse interaction between steroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Neurology; 1974 May; 24(5):442-9. PubMed ID: 4363816
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239
    [No Abstract]   [Full Text] [Related]  

  • 15. Dropped head as an unusual presenting sign of myasthenia gravis.
    D'Amelio M; Di Benedetto N; Ragonese P; Daniele O; Brighina F; Fierro B; Savettieri G
    Neurol Sci; 2007 Apr; 28(2):104-6. PubMed ID: 17464475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of myasthenia gravis.
    Preswick G
    Acta Med Philipp; 1966; 2(3):157-8. PubMed ID: 5915027
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of myasthenia gravis.
    Lazar A
    J Assoc Physicians India; 1991 Aug; 39(8):655. PubMed ID: 1814893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of the physiopathology and treatment of myasthenia gravis].
    Vázquez A; Fernández O
    Rev Clin Esp; 1978 May; 149(4):321-6. PubMed ID: 694105
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis. Emergency treatment.
    Kennedy WR
    Minn Med; 1968 Sep; 51(9):1291-3. PubMed ID: 5679230
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology of myasthenia gravis.
    Dipalma JR
    Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.